Is increased chronological age a contraindication to debulking surgery for elderly patients with advanced ovarian cancer?

被引:1
|
作者
Park, Soo Jin [1 ]
Mun, Jaehee [1 ]
Yim, Ga Won [2 ]
Lee, Maria [1 ]
Chung, Hyun Hoon [1 ]
Kim, Jae Weon [1 ]
Park, Noh Hyun [1 ]
Song, Yong Sang [1 ]
Kim, Hee Seung [1 ]
机构
[1] Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
[2] Dongguk Univ, Dept Obstet & Gynecol, Coll Med, Goyang, South Korea
关键词
Aged; ovarian neoplasm; postoperative complications; prognosis; surgical procedure; CYTOREDUCTIVE SURGERY; CHEMOTHERAPY; MORBIDITY; COMORBIDITY; TOXICITY; OUTCOMES; RISK;
D O I
10.1080/01443615.2022.2112021
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
We collected data of elderly patients aged 65 years and older who underwent debulking surgery for advanced ovarian cancer in order to explore the impact of old age on surgical outcomes and complications. A total of 120 patients were classified as follows: group 1, 65-69 years (n = 58); group 2, 70-74 years (n = 38); group 3, 75-79 years (n = 17); group 4, >= 80 years (n = 7). There were no differences in most of the characteristics, surgical extent and outcomes, and postoperative complications between the four groups, whereas polypharmacy was more common (6 vs. 5-16; p=.02) and operation time was shorter (median, 194 vs. 285-330 min; p=.02) in group 4. Factors related to frailty rather than age, polypharmacy, preoperative albumin level, estimated blood loss and transfusion increased the risk of postoperative complications. Thus, the impact of old age on surgical extent, outcomes and postoperative complications may be minimal in elderly patients with advanced ovarian cancer. Impact Statement What is already known on this subject? Optimal debulking surgery is a significant factor in improving the prognosis of ovarian cancer but it is not easy to perform such radical surgery on elderly patients in fear of increasing surgical morbidity and mortality. Some studies suggest that underlying comorbidities may be a stronger contributing factor to increasing such risk rather than old age although there is not enough evidence yet. What do the results of this study add? Through this study, we could see that increased age is not the determining cause of increased morbidity and mortality in elderly patients who undergo optimal debulking surgery in ovarian cancer. There are other aspects describing a patient's health status that can predict prognosis better rather than age. What are the implications of these findings for clinical practice and/or further research? Old age need not be a contraindication when performing optimal debulking surgery in elderly patients with advanced ovarian cancer.
引用
下载
收藏
页码:3254 / 3259
页数:6
相关论文
共 50 条
  • [31] Outcome of patients undergoing delayed debulking surgery (DDS) in advanced ovarian cancer (OC).
    Crusz, Shanthini M.
    Chandrasekaran, Dhivya
    Phadnis, Saurabh
    Delvin, Michael John
    Quigley, Mary
    Powell, Melanie E.
    Jeyarajah, Arjun
    Oram, David
    Lawrence, Alexandra
    Singh, Naveena
    Manchanda, Ranjit
    Brockbank, Elly
    Miller, Rowan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [32] Outcome of Interval Debulking in Advanced Ovarian Cancer Patients
    Suprasert, Prapaporn
    Tiyanon, Jittima
    Kietpeerakool, Chumnarn
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2008, 9 (03) : 519 - 523
  • [33] Laparotomy versus minimally invasive surgery for interval debulking surgery among patients with advanced ovarian cancer
    Jorgensen, Kirsten
    Wu, Chi-Fang
    Nitecki, Roni
    Schorge, John
    Melamed, Alexander
    Ramirez, Pedro
    Rauh-Hain, Jose
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S19 - S19
  • [34] Benign biliary pathology in elderly patients: is age a contraindication to surgery?
    Luri, P
    Compan, AF
    Medrano, J
    Garcia, S
    Picon, G
    Merono, E
    Diez, M
    VanderHofstadt, J
    MartinezAbarca, R
    HAMBURG '97 - EUROPEAN I.H.P.B.A. CONGRESS, 1997, : 457 - 461
  • [35] Total parietal peritonectomy in primary debulking surgery for advanced ovarian cancer
    Yokosu, Kota
    Tanabe, Hiroshi
    Nomura, Shogo
    Ozone, Hirokazu
    Saito, Motoaki
    Takano, Hirokuni
    Okamoto, Aikou
    GYNECOLOGIC ONCOLOGY REPORTS, 2021, 37
  • [36] The place of bowel resection in initial debulking surgery for advanced ovarian cancer
    Miller, J
    Prioetto, A
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2002, 42 (05): : 535 - 537
  • [37] Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer
    Vergote, IB
    De Wever, I
    Decloedt, J
    Tjalma, W
    Van Gramberen, M
    van Dam, P
    SEMINARS IN ONCOLOGY, 2000, 27 (03) : 31 - 36
  • [38] Clinical significance of primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery in advanced ovarian cancer
    Nishio, Shin
    Ushijima, Kimio
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (04) : 379 - 386
  • [39] Primary debulking surgery for advanced ovarian cancer: Are you a believer or a dissenter?
    Schorge, John O.
    Clark, Rachel M.
    Lee, Susanna I.
    Penson, Richard T.
    GYNECOLOGIC ONCOLOGY, 2014, 135 (03) : 595 - 605
  • [40] Primary debulking surgery for advanced ovarian cancer: Is it the past, present, or future?
    Schorge, J.
    McCann, C.
    Growdon, W.
    Boruta, D.
    Del Carmen, M.
    Goodman, A.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S130 - S130